110 related articles for article (PubMed ID: 24783828)
1. Diagnosis and management of potentially malignant oral disorders.
De Silva HL
Ann R Australas Coll Dent Surg; 2012 Apr; 21():60-2. PubMed ID: 24783828
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Oral Dysplasia.
Clarkson E; Hadioonzadeh R; Peters SM
Dent Clin North Am; 2024 Jan; 68(1):133-149. PubMed ID: 37951630
[TBL] [Abstract][Full Text] [Related]
3. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
[TBL] [Abstract][Full Text] [Related]
4. Inter- and Intra-Observer Variability in Diagnosis of Oral Dysplasia.
R SA; B N P; Hegde U; K U; G S; G K; Sil S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3251-3254. PubMed ID: 29286215
[TBL] [Abstract][Full Text] [Related]
5. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.
Nikitakis NG; Pentenero M; Georgaki M; Poh CF; Peterson DE; Edwards P; Lingen M; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):650-669. PubMed ID: 29709496
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic aids for detection of oral precancerous conditions.
Messadi DV
Int J Oral Sci; 2013 Jun; 5(2):59-65. PubMed ID: 23743617
[TBL] [Abstract][Full Text] [Related]
8. Oral premalignancy: new methods of detection and treatment.
Gillenwater A; Papadimitrakopoulou V; Richards-Kortum R
Curr Oncol Rep; 2006 Mar; 8(2):146-54. PubMed ID: 16507225
[TBL] [Abstract][Full Text] [Related]
9. [Potentially malignant disorders of the oral mucosa].
Ben Slama L
Rev Prat; 2019 Oct; 69(8):856-860. PubMed ID: 32237647
[TBL] [Abstract][Full Text] [Related]
10. Oral leukoplakia remains a challenging condition.
Villa A; Sonis S
Oral Dis; 2018 Mar; 24(1-2):179-183. PubMed ID: 29480606
[TBL] [Abstract][Full Text] [Related]
11. Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?
Pritzker KPH; Darling MR; Hwang JT; Mock D
Expert Rev Mol Diagn; 2021 Mar; 21(3):289-298. PubMed ID: 33682567
[TBL] [Abstract][Full Text] [Related]
12. Oral Potentially Malignant Disorders and Oral Cavity Cancer.
Ojeda D; Huber MA; Kerr AR
Dermatol Clin; 2020 Oct; 38(4):507-521. PubMed ID: 32892859
[TBL] [Abstract][Full Text] [Related]
13. Consensus guidelines on management of oral potentially malignant disorders.
Birur PN; Patrick S; Warnakulasuriya S; Gurushanth K; Raghavan SA; Rath GK; Chaturvedi P; Chandru V; Mathew B; Prabhash K; Gurudath S; Mukhia N; Sunny SP; Mehrotra R; Vivek V; Patil S; Kumar GS; Fasalkar S; Pratima R; Kuriakose MA
Indian J Cancer; 2022; 59(3):442-453. PubMed ID: 36412324
[TBL] [Abstract][Full Text] [Related]
14. Oral epithelial dysplasia: Recognition, grading and clinical significance.
Odell E; Kujan O; Warnakulasuriya S; Sloan P
Oral Dis; 2021 Nov; 27(8):1947-1976. PubMed ID: 34418233
[TBL] [Abstract][Full Text] [Related]
15. Potentially premalignant disorder/lesion versus potentially premalignant patient: Relevance in clinical care.
Ilhan B; Epstein JB; Guneri P
Oral Oncol; 2019 May; 92():57-58. PubMed ID: 31010624
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of contemporary oral epithelial dysplasia grading systems.
Sathasivam HP; Sloan P; Thomson PJ; Robinson M
J Oral Pathol Med; 2022 Feb; 51(2):180-187. PubMed ID: 34797585
[TBL] [Abstract][Full Text] [Related]
17. Whether cancer stem cell markers can serve as the markers for malignant progression of oral potentially malignant disorders.
Liu W; Zhou Z; Yang X; Shi H
Oral Dis; 2022 Oct; 28(7):2057-2058. PubMed ID: 34837299
[No Abstract] [Full Text] [Related]
18. Management of oral potentially malignant disorders.
Kerr AR; Lodi G
Oral Dis; 2021 Nov; 27(8):2008-2025. PubMed ID: 34324758
[TBL] [Abstract][Full Text] [Related]
19. Oral Cancer Update: 2017.
Rhodus NL
Northwest Dent; 2017 Jan; 96(1):21-3, 25-7. PubMed ID: 30549746
[No Abstract] [Full Text] [Related]
20. Metformin and oral cancer: In reply with emphasis on an emerging role of an old drug in oral cancer chemoprevention.
Zhu L; Deng Y; Ji T; Zhou H; Liu W
Oral Oncol; 2022 Dec; 135():106196. PubMed ID: 36257182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
